Kyungpook National Hospital
Jung-gu, Daegu, 700-721, South Korea
NCT Number: NCT02029625
The purpose of this study is to compare the pharmacokinetics of NVP-1205 and coadministration of rosuvastatin and ezetimibe.
Looking for future studies?
Notify Me19 year–55 year
Male
Interventional
Phase 1
Jung-gu, Daegu, 700-721, South Korea
rosuvastatin and ezetimibe(anti-dyslipidemia)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
rosuvastatin/ezetimibe fixed dose combination orally, once daily on Period 1 or Period 2
Other names: NVP-1205(rosuvastatin+ezetimibe)
coadministration of rosuvastatin and ezetimibe orally, once daily on Period 1 or Period 2
Other names: Crestor and Ezetrol
Time frame: 0-96hr
Time frame: 0-96hr
NVP Healthcare
Industry
A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe in Healthy Male Volunteers
Acronym: NVP-1205
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07655960
Dyslipidemia, Dyslipidemias
Seoul, South Korea
View Trial DetailsNCT07691268
Dyslipidemia, Dyslipidemias
Seoul, Gwanak-gu 08779, South Korea
View Trial DetailsNCT07627555
Cardiovascular Diseases, Dyslipidemia
Lahore, Pakistan
View Trial DetailsNCT00001154
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia
Bethesda, Maryland, United States
View Trial Details